Socioeconomic factors associated with drug consumption in Mexico.

J Addict Dis

Universidad Nacional Tres de Febrero, Buenos Aires, Argentina.

Published: April 2022

Background: Illicit drug consumption in Mexico has been growing constantly and has begun to be a public health problem. The aim of this study is to identify the principal characteristics and socioeconomic variables associated with consumption of illegal drugs in Mexico.

Methods: Using information from the 2016 national addictions survey in Mexico, we develop a logistic regression model to determine the variables associated with drug consumption, sometime in lifetime or recently, in the general population of Mexico.

Results: Analyzing information from 56,877 persons, the prevalence of the use of illicit drugs at least once in lifetime was 15.4% and 3.6% for males and females, respectively. The variables associated with more consumption of illegal drugs was utilization of substances with alcohol (RR 9.3; 95% CI 7.9-10.8) and nicotine products (RR 4.7; 95% CI 4.3-5.1), male gender (RR 2.6; 95% CI 2.4-2.8), and relatives' drug consumption (RR 2.1; 95% CI 1.8-2.4).

Conclusions: Having more education, being older, and having a partner was associated with lower illicit drug consumption sometime in lifetime; in the case of recent consumption, in addition, having a job or active child-rearing in the house in a positive sense.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10550887.2021.1919486DOI Listing

Publication Analysis

Top Keywords

drug consumption
20
variables associated
12
associated drug
8
consumption
8
consumption mexico
8
illicit drug
8
associated consumption
8
consumption illegal
8
illegal drugs
8
consumption lifetime
8

Similar Publications

To evaluate weight change with a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine by pooling data across clinical studies. This study was an individual patient data (IPD) meta-analysis of clinical trial data. EMBASE, MEDLINE, and PsycInfo were searched for randomized clinical trials (≥12 weeks) in adults with schizophrenia or bipolar I disorder in which weight change from baseline was the primary or secondary end point.

View Article and Find Full Text PDF

Background: Nursing home (NH) residents are frequently treated with antibiotics for urinary tract infections (UTIs), often due to overdiagnosis. The aim of this study was to evaluate the proportion of potentially unnecessary antibiotic use for suspected UTIs in NHs across eight European countries.

Research Design And Methods: Over a three-month period (February to April 2024), NH professionals recorded information on all antibiotic treatments for UTIs using a specific registration chart.

View Article and Find Full Text PDF

Hydrodynamic radius () is a descriptive metric of protein structure with the potential to impact drug development, disease diagnosis, and other important research areas of molecular biology. Common instrumental methods for molecular size characterization are disadvantageous due to high sample consumption, measurements made in non-physiological conditions, and/or inaccurate size determinations. Capillary Taylor dispersion analysis (TDA) is a molecular sizing method that utilizes nL sample volumes and achieves absolute size determination without calibration or comparison to standards.

View Article and Find Full Text PDF

Purpose: To explore the postoperative opioid-sparing effect and incidence of adverse events of different dosages of intraoperative esketamine administration in patients undergoing laparoscopic gynecological surgery.

Patients And Methods: Patients undergoing elective gynecological laparoscopic operation was enrolled and randomly allocated to lower-dose esketamine group, higher-dose esketamine group, or control group. Patients in the two intervention groups received esketamine doses of 0.

View Article and Find Full Text PDF

Background: Obinutuzumab was approved in China in June 2021 used in combination with chemotherapy (followed by obinutuzumab maintenance) for the treatment of adult patients with previously untreated stage II bulky, III, or IV follicular lymphoma (FL). The clinical application of obinutuzumab has recently begun in China, but there is a lack of evidence to determine under which circumstances it should be considered the treatment of choice. A comprehensive assessment is necessary to evaluate the efficacy, safety, and cost-effectiveness of obinutuzumab in adult patients with FL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!